Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population

Clinical trial NCT02000531 · COMPLETED

Trial details

NCT number: NCT02000531
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2014-01-01
Primary completion: 2014-12-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.